What if we could teach the body to regrow bone?

A new material developed by researchers in Australia doesn’t simply fill damaged bone. It prompts the body to start rebuilding it itself.

For children born with cleft lip and palate, repairing a gap in the jawbone can mean waiting until the age of 10 or 12 for surgery.

The procedure often involves taking bone from elsewhere in the child’s body and grafting it into the jaw – an invasive approach that has changed relatively little in decades.

But new research reported by Surgery International points to a very different possibility: instead of replacing what’s missing, could we persuade the body to grow it back?

Researchers at the University of Sydney and University of Queensland have developed a biodegradable material they’ve nicknamed “nanobone”.

Switching repair back on

Made from calcium, aluminium and silicate at the nanoscale, the material works by activating repair signals that already exist within the body. One of those signals attracts bone-forming stem cells to the damaged area and encourages them to become cells capable of producing new bone.

In preclinical research, the material produced around 80% more new bone after eight weeks than the control material. It also activated a key bone-repair growth factor at around 10 times the level achieved using conventional methods.

It can also encourage blood to clot within around 30 seconds, helping create the conditions for healing almost immediately.

Then, as new bone develops, the biodegradable material is gradually replaced by the body’s own tissue.

From replacement to regeneration

The research is still preclinical. Human trials haven’t begun, and there’s a long way to go before “nanobone” could become part of routine treatment.

But its potential extends beyond cleft lip and palate. Researchers believe the same approach could eventually be explored for traumatic injuries, tooth loss and other difficult-to-repair bone defects. They’re also investigating personalised 3D-printed scaffolds shaped to an individual patient’s injury.

That points towards a wider shift already happening across medicine.

For a long time, repairing the human body has often meant replacing what’s damaged – with grafts, implants, prosthetics or donor tissue.

Regenerative medicine asks a different question: what if the body already has more of the machinery needed to repair itself than we realise?

The innovation may not be creating the replacement.

It may be learning how to switch the repair process back on.